Innoveren Scientific Inc.

IVRN

US4041243076

Advanced Medical Equipment & Technology

Market Closed - OTC Markets Other stock markets 12:27:09 04/06/2024 am IST			5-day change	1st Jan Change
0.0036 ^USD	-34.55%		0.00%	-96.90%

04/06	Innoveren Scientific Inc. announced that it has received $0.25 million in funding	CI
06/03	Innoveren Scientific Announces 510(K) Submission to U.S. Federal Food and Drug Administration for Skindisc(Tm) Lite	CI

H-CYTE, Inc. Moves its Headquarters

April 05, 2022 at 02:00 am IST

H-CYTE, Inc. announced that on April 1, 2022, the company moved its headquarters to 2202 N. West Shore Blvd, Suite 200, Tampa, FL 33607.

Latest news about Innoveren Scientific Inc.

Innoveren Scientific Inc. announced that it has received $0.25 million in funding	04/06	CI
Innoveren Scientific Announces 510(K) Submission to U.S. Federal Food and Drug Administration for Skindisc(Tm) Lite	06/03	CI
Innoveren Scientific Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11	CI
Innoveren Scientific Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/11	CI
H-Cyte, Inc. has Changed its Name to Innoveren Scientific Inc	10/23/10	CI
Innoveren Scientific Inc. has Changed its Ticker to IVRN from HCYT	10/23/10	CI
H-CYTE, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23/23/23	CI
H-CYTE, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	11/23/11	CI
H-CYTE, Inc. Auditor Raises 'Going Concern' Doubt	10/23/10	CI
H-CYTE, Inc. announced that it expects to receive $0.135 million in funding	12/23/12	CI
H-CYTE, Inc. announced that it expects to receive $0.3 million in funding	24/23/24	CI
H-CYTE, Inc. (OTCQB: HCYT) completed the acquisition of SkinDisc from Tanya Rhodes, Brock Liden, Spencer T Brown and Spencer T Brown.	29/22/29	CI
H-CYTE, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/22/15	CI
H-CYTE, Inc. announced that it has received $0.225 million in funding	29/22/29	CI
H-CYTE, Inc. (OTCQB: HCYT) entered into a letter of intent to acquire SkinDisc from Tanya Rhodes, Brock Liden, Spencer T Brown and Spencer T Brown for $2.3 million.	19/22/19	CI
H-CYTE, Inc. cancelled the acquisition of Catheter Precision, Inc.	08/22/08	CI
H-CYTE, Inc. acquired Jantibody, LLC.	08/22/08	CI
H-CYTE, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	13/22/13	CI
H-Cyte, Inc. Closes Its Clinic in Scottsdale, Arizona	10/22/10	CI
H-CYTE, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	05/22/05	CI
H-CYTE, Inc. Moves its Headquarters	05/22/05	CI
H-CYTE, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	26/22/26	CI
H-CYTE, Inc. Auditor Raises 'Going Concern' Doubt	25/22/25	CI
H-CYTE, Inc. Appoints Richard Rosenblum and Matthew Anderer as Directors	15/22/15	CI
H-CYTE, Inc. entered into a letter of intent to acquire Catheter Precision, Inc.	11/22/11	CI

Chart Innoveren Scientific Inc.

Duration

Period

More charts

Innoveren Scientific Inc. is a life science and biotech incubator company. The Company is focused on advancing new technologies in areas of unmet need across multiple indications for improving patient lives. The Company is also focused on investing in and fosters technologies that are supported by a scientific foundation.

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
INNOVEREN SCIENTIFIC INC.	-96.90%	19.22T
THERMO FISHER SCIENTIFIC	+4.18%	21TCr
DANAHER CORPORATION	+8.00%	19TCr
INTUITIVE SURGICAL, INC.	+31.86%	16TCr
BOSTON SCIENTIFIC CORPORATION	+33.21%	11TCr
SIEMENS HEALTHINEERS AG	+2.28%	6.43TCr
EDWARDS LIFESCIENCES CORPORATION	+21.14%	5.57TCr
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+0.11%	4.84TCr
AGILENT TECHNOLOGIES, INC.	-6.76%	3.78TCr
GE HEALTHCARE TECHNOLOGIES INC.	+0.78%	3.56TCr